The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythemia - Cheung,B.; Radia,D.; Pantedelis,P.; Yadergarfar,G.; Harrison,C. (Br J Haematol, 2005)